OCULAR THERAPEUTIX, INC - COM (OCUL)

Historical Portfolio Holders from Q3 2014 to Q1 2024

All holders as of March 31, 2024: Q1 2024
Type / Class: Equity / COM
Shares, excl. options Q1 2024: 122 M
Holdings value Q1 2024: $1.1 B
Value change Q1 2024: +$444 M
Grand Portfolio weight change Q1 2024: +0.001%
Number of holders: 139
Number of buys Q1 2024: 99
Number of sells Q1 2024: -39
Average buys Q1 2024 %: +0.029%
Average sells Q1 2024 %: 0%
CUSIP: 67576A100

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Period	Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2024 Q1	122 M	$1.1 B	+$444 M	4.61 M	1.23 M	$9.10	139
2023 Q4	73.1 M	$326 M	+$150 M	653 K	518 K	$4.46	115
2023 Q3	40.2 M	$126 M	-$13.9 M	235 K	508 K	$3.14	109
2023 Q2	43.2 M	$223 M	+$13.4 M	1.72 M	2.05 M	$5.16	130
2023 Q1	40.1 M	$211 M	+$6.22 M	1.76 M	3.62 M	$5.27	123
2022 Q4	39.4 M	$111 M	-$12 M	633 K	774 K	$2.81	106
2022 Q3	42.6 M	$177 M	-$4.08 M	1.28 M	2.18 M	$4.15	123
2022 Q2	43.6 M	$175 M	+$1.51 M	178 K	440 K	$4.02	116
2022 Q1	43.2 M	$214 M	+$8.63 M	829 K	759 K	$4.95	123
2021 Q4	35.6 M	$248 M	-$35.5 M	1.95 M	1.92 M	$6.97	131
2021 Q3	44.3 M	$444 M	-$46.2 M	6.63 M	11.2 M	$10.00	135
2021 Q2	48.2 M	$684 M	+$13.9 M	7.09 M	18.4 M	$14.18	142
2021 Q1	47.1 M	$773 M	-$64.9 M	6.11 M	7.5 M	$16.41	146
2020 Q4	50.1 M	$1.04 B	+$212 M	4.11 M	10.5 M	$20.70	142
2020 Q3	39.7 M	$302 M	+$7.13 M	1.82 M	1.53 M	$7.61	99
2020 Q2	38.7 M	$322 M	+$85.3 M	2.02 M	3.81 M	$8.33	103
2020 Q1	28.5 M	$141 M	+$17.9 M	481 K	2.14 M	$4.95	87
2019 Q4	22.4 M	$88.3 M	+$5.75 M	156 K	647 K	$3.95	73
2019 Q3	23.1 M	$70.2 M	+$1.03 M	383 K	240 K	$3.04	69
2019 Q2	19.4 M	$85.2 M	+$2.81 M	595 K	650 K	$4.40	60
2019 Q1	19.5 M	$77.2 M	+$2.21 M	172 K	348 K	$3.97	63
2018 Q4	18.7 M	$74.3 M	-$5.8 M	386 K	492 K	$3.98	62
2018 Q3	21.6 M	$149 M	-$1.51 M	682 K	1.2 M	$6.88	69
2018 Q2	21.8 M	$147 M	+$9.62 M	313 K	877 K	$6.75	61
2018 Q1	20.4 M	$133 M	+$45.7 M	573 K	1.02 M	$6.51	63
2017 Q4	12 M	$53.6 M	-$12 M	377 K	290 K	$4.45	64
2017 Q3	15.6 M	$96.5 M	-$1.1 M	1.03 M	867 K	$6.18	70
2017 Q2	15.2 M	$141 M	-$26.3 M	1.73 M	1.58 M	$9.27	71
2017 Q1	18.3 M	$170 M	+$20.3 M	1.31 M	2.7 M	$9.28	74
2016 Q4	17.4 M	$145 M	-$9.99 M	631 K	1.09 M	$8.37	76
2016 Q3	18.8 M	$129 M	-$2.94 M	976 K	1.23 M	$6.87	71
2016 Q2	19.4 M	$96.1 M	-$30.4 M	182 K	365 K	$4.95	72
2016 Q1	20.9 M	$201 M	-$1.63 M	136 K	617 K	$9.66	64
2015 Q4	21 M	$196 M	-$18.1 M	0	124 K	$9.37	70
2015 Q3	20 M	$282 M	+$49 M	711 K	404 K	$14.06	66
2015 Q2	16.1 M	$337 M	+$93 M			$21.03	70
2015 Q1	10.7 M	$449 M	+$241 M			$41.98	55
2014 Q4	5.01 M	$118 M	+$9.26 M			$23.52	36
2014 Q3	4.63 M	$69.3 M	+$69.3 M			$14.97	33